Forbright Inc (FRBT)
NASDAQFinancialsBanks - DiversifiedSnapshot 2026-10-23
$17.40+1.28%
Close 2026-10-23 · 1-day change
NASDAQFinancialsBanks - DiversifiedSnapshot 2026-10-23
Research Workspace
Put FRBT beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisModerate volatility — typically moves about 1% a day.
View RiskNot enough reads yet
FRBT’s case rests on interest-rate benefits, though the desk records no earnings history to confirm growth. The latest release is also missing, so the recent trajectory and result cannot be verified. No clean valuation multiple is available, leaving the valuation comparison low-confidence. The price is roughly in line with forecast growth. A next-quarter miss probability of 30% makes a further earnings miss a concrete risk. Peer multiples imply a price about 23% above where it trades. Our read remains intact, though this read is provisional.
Trailing returns as of 2026-10-23. FRBT is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering FRBT (as of Oct 2026).
Based on 4 Wall Street analysts offering 12-month price targets for FRBT in the last 4 months.
Continue this research
Compare FRBT with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| FRBT Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-10-23. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put FRBT next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Upgrade suggests positive outlook on stock valuation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-23. EPS is implied from price ÷ P/E. Not investment advice.
Current $17.40
The last 12 months of price, then the range of analyst 12-month targets from today’s $17.40.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Significant acquisition enhances Forbright's financial position.
Branch sale improves liquidity and focus.
Acquisition details confirm strategic divestiture.
Official announcement of acquisition supports growth strategy.
Acquisition of branches aligns with strategic objectives.
Reinforces strategic focus through branch acquisition.
